Newish Biotech (Wuxi) Co., Ltd.
Newish Biotech (Wuxi) Co., Ltd.
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of NWRD09 for HPV-16 Related Cervical HSIL | Morphological and Microscopic Findings, Pathological Conditions, Signs and Symptoms, Squamous Intraepithelial Lesions | Not yet recruiting | Phase 2 | 2026-07-17 | NCT07712692 | |
| NWRD09 for Persistent Cervical HPV16 Infection | Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Persistent Infection | Recruiting | Not applicable | 2026-07-17 | NCT07710703 | |
| A Study of NWRD09 in Participants With Persistent HPV16 Infection in the Anal Region | Persistent HPV16 Infection | Recruiting | Phase 1 | 2026-07-17 | NCT07710664 | |
| Evaluation of NWRD09 for Female Participants With Persistent HPV16 Infection | Persistent HPV16 Infection | Not yet recruiting | Phase 1 / Phase 2 | 2026-04-17 | NCT07536282 | |
| Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL | Morphological and Microscopic Findings, Pathological Conditions, Signs and Symptoms, Squamous Intraepithelial Lesions | Recruiting | Phase 2 | 2026-02-17 | NCT07175662 | |
| NWRD09 for HPV-16 Related Cervical HSIL | Morphological and Microscopic Findings, Pathological Conditions, Signs and Symptoms, Squamous Intraepithelial Lesions | Recruiting | Phase 1 | 2025-07-02 | NCT07047989 |